Recombinant Canine IL-1 beta/IL-1F2 Protein
R&D Systems, Inc. a Bio-Techne Brand
Key Product Details
Source: | E. coli |
Accession #: | NP_001033060 |
Applications: | Bioactivity |
Customers also Viewed
Customers also Purchased
Citations for Recombinant Canine IL-1 beta/IL-1F2 Protein (3)
Citations are publications that use Bio-Techne products. Selected citations for Recombinant Canine IL-1 beta/IL-1F2 Protein include:
-
Species: Canine
Sample Types: Whole Cells
Applications: BioassayV Konduri et al. (2019), Dendritic cell vaccination plus low-dose doxorubicin for the treatment of spontaneous canine hemangiosarcoma Cancer Gene Ther., 0(0).
PMID: 30670791 -
Species: Canine
Sample Types: Whole Cells
Applications: BioassayJ Thalmensi et al. (2019), A DNA telomerase vaccine for canine cancer immunotherapy Oncotarget, 10(36):3361-3372.
PMID: 31164958 -
Species: Canine
Sample Types: Whole Tissue
Applications: BioassayM Ogawa et al. (2018), Effect of interleukin-1? on occludin mRNA expression in the duodenal and colonic mucosa of dogs with inflammatory bowel disease J. Vet. Intern. Med., 0(0).
PMID: 29572935
There are no citations that match your criteria.
FAQs for Recombinant Canine IL-1 beta/IL-1F2 Protein
-
Does IL-1 beta induce NO in smooth muscle?
Yes it does, based on the literature.